These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38367235)

  • 1. Protocol to generate traceable CAR T cells for syngeneic mouse cancer models.
    Zhang D; Krimitza E; Han K; Su R; Xu DJ; Xu JR; Gong Y; Fan Y
    STAR Protoc; 2024 Mar; 5(1):102898. PubMed ID: 38367235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models.
    Li N; Nguyen R; Thiele CJ; Ho M
    STAR Protoc; 2021 Dec; 2(4):100942. PubMed ID: 34825213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.
    Pituch KC; Miska J; Krenciute G; Panek WK; Li G; Rodriguez-Cruz T; Wu M; Han Y; Lesniak MS; Gottschalk S; Balyasnikova IV
    Mol Ther; 2018 Apr; 26(4):986-995. PubMed ID: 29503195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of hypoxia-sensing chimeric antigen receptor T cells.
    Kosti P; Larios-Martinez KI; Maher J; Arnold JN
    STAR Protoc; 2021 Sep; 2(3):100723. PubMed ID: 34401788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical Study.
    Kim K; Gwak HS; Han N; Hong EK; Choi BK; Lee S; Choi S; Park JH; Seok JH; Jeon Y; Cho H; Lee SJ; Lee Y; Nam KT; Song SW
    Front Immunol; 2021; 12():715000. PubMed ID: 34819930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model.
    Ranoa DRE; Sharma P; Schane CP; Lewis AN; Valdez E; Marada VVVR; Hager MV; Montgomery W; Wolf SP; Schreiber K; Schreiber H; Bailey K; Fan TM; Hergenrother PJ; Roy EJ; Kranz DM
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.
    Siegler EL; Wang P
    Hum Gene Ther; 2018 May; 29(5):534-546. PubMed ID: 29390873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer.
    Rotolo A; Atherton MJ; Kasper BT; Haran KP; Mason NJ
    STAR Protoc; 2021 Dec; 2(4):100905. PubMed ID: 34746864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures.
    Selli ME; Landmann JH; Arveseth C; Singh N
    STAR Protoc; 2023 Mar; 4(1):101954. PubMed ID: 36607811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transwell migration assay to interrogate human CAR-T cell chemotaxis.
    Oner A; Kobold S
    STAR Protoc; 2022 Dec; 3(4):101708. PubMed ID: 36136753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression.
    Lanitis E; Rota G; Kosti P; Ronet C; Spill A; Seijo B; Romero P; Dangaj D; Coukos G; Irving M
    J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33156338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
    Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Brakel BA; Chokshi CR; Salim SK; Venugopal C; Singh S
    STAR Protoc; 2021 Dec; 2(4):100920. PubMed ID: 34761232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to Test Human CAR T Cells in Solid Tumors, the Next Frontier of CAR T Cell Therapy.
    Cochrane RW; Fiorentino A; Allen E; Robino RA; Quiroga J; Ferreira LMR
    Methods Mol Biol; 2024; 2748():243-265. PubMed ID: 38070118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.
    Watanabe K; Luo Y; Da T; Guedan S; Ruella M; Scholler J; Keith B; Young RM; Engels B; Sorsa S; Siurala M; Havunen R; Tähtinen S; Hemminki A; June CH
    JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells.
    Vincent RL; Li F; Ballister ER; Arpaia N; Danino T
    J Vis Exp; 2024 Feb; (204):. PubMed ID: 38372353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity.
    Haydar D; Ibañez-Vega J; Crawford JC; Chou CH; Guy CS; Meehl M; Yi Z; Perry S; Laxton J; Cunningham T; Langfitt D; Vogel P; DeRenzo C; Gottschalk S; Roussel MF; Thomas PG; Krenciute G
    Cancer Res Commun; 2023 Dec; 3(12):2430-2446. PubMed ID: 37971169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells.
    Kueberuwa G; Zheng W; Kalaitsidou M; Gilham DE; Hawkins RE
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30394400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer.
    Kandra P; Nandigama R; Eul B; Huber M; Kobold S; Seeger W; Grimminger F; Savai R
    Front Immunol; 2022; 13():903562. PubMed ID: 35720364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD70, a novel target of CAR T-cell therapy for gliomas.
    Jin L; Ge H; Long Y; Yang C; Chang YE; Mu L; Sayour EJ; De Leon G; Wang QJ; Yang JC; Kubilis PS; Bao H; Xia S; Lu D; Kong Y; Hu L; Shang Y; Jiang C; Nie J; Li S; Gu Y; Sun J; Mitchell DA; Lin Z; Huang J
    Neuro Oncol; 2018 Jan; 20(1):55-65. PubMed ID: 28651374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.